Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

Reinhard Stauder, Ge Yu, Karin A. Koinig, Timothy Charles Bagguley, Pierre Fenaux, Argiris Symeonidis, Guillermo Sanz, Jaroslav Cermak, Moshe Mittelman, Eva Hellström-Lindberg, Saskia Langemeijer, Mette Skov Holm, Krzysztof Mądry, Luca Malcovati, Aurelia Tatic, Ulrich Germing, Aleksandar Savic, Corine van Marrewijk, Agnès Guerci-Bresler, Elisa LuñoJackie Droste, Fabio Efficace, Alexandra Gwen Smith, David Bowen, Theo de Witte

Research output: Contribution to journalArticlepeer-review

Abstract

In myelodysplastic syndromes (MDS), health-related quality of life (HRQoL) represents a relevant patient-reported outcome, which is essential in individualized therapy planning. Prospective data on HRQoL in lower-risk MDS remain rare. We assessed HRQOL by EQ-5D questionnaire at initial diagnosis in 1690 consecutive IPSS-Low/Int-1 MDS patients from the European LeukemiaNet Registry. Impairments were compared with age- and sex-matched EuroQol Group norms. A significant proportion of MDS patients reported moderate/severe problems in the dimensions pain/discomfort (49.5%), mobility (41.0%), anxiety/depression (37.9%), and usual activities (36.1%). Limitations in mobility, self-care, usual activities, pain/discomfort, and EQ-VAS were significantly more frequent in the old, in females, and in those with high co-morbidity burden, low haemoglobin levels, or red blood cells transfusion need (p 
Original languageEnglish
Number of pages26
JournalLeukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K
Early online date6 Mar 2018
DOIs
Publication statusE-pub ahead of print - 6 Mar 2018

Bibliographical note

© 2018 Macmillan Publishers Limited, part of Springer Nature. All rights reserved

Cite this